CA
RCEL icon

Cliff Asness’s Avita Medical RCEL Stock Holding History

Cliff Asness’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
321,013
+226,652
+240% +$978K ﹤0.01% 2856
2026
Q1 		$349K Sell
94,361
-7,131
-7% -$29.9K ﹤0.01% 3333
2025
Q4 		$350K Sell
101,492
-17,796
-15% -$71K ﹤0.01% 3103
2025
Q3 		$610K Buy
119,288
+97,365
+444% +$508K ﹤0.01% 2711
2025
Q2 		$116K Sell
21,923
-76,214
-78% -$554K ﹤0.01% 3152
2025
Q1 		$799K Buy
+98,137
New +$917K ﹤0.01% 2166
2024
Q4 		– Sell
-15,957
Closed -$171K – 2933
2024
Q3 		$171K Sell
15,957
-7,108
-31% -$66.8K ﹤0.01% 2593
2024
Q2 		$183K Sell
23,065
-67,535
-75% -$642K ﹤0.01% 2438
2024
Q1 		$1.45M Buy
90,600
+28,391
+46% +$459K ﹤0.01% 1537
2023
Q4 		$854K Buy
62,209
+51,967
+507% +$596K ﹤0.01% 1657
2023
Q3 		$150K Buy
+10,242
New +$173K ﹤0.01% 2182
2022
Q3 		– Sell
-10,086
Closed -$48K – 2298
2022
Q2 		$48K Buy
+10,086
New +$62.3K ﹤0.01% 2137

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Cliff Asness's RCEL Position: Q2 2026 in Review

Cliff Asness increased its Avita Medical (RCEL) stake by 240% in Q2 2026, buying an estimated $978K and bringing the position to 321,013 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Cliff Asness first reported a position in RCEL in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.45M in Q1 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Cliff Asness held 321,013 shares of Avita Medical worth $1.33M as of Q2 2026.
  • Cliff Asness bought 226,652 Avita Medical shares in Q2 2026, an estimated $978K.
  • Avita Medical made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2856 holding.
  • Cliff Asness first reported a position in Avita Medical in Q2 2022 and has held it in 12 quarters since.
  • Cliff Asness's Avita Medical position peaked at $1.45M in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.